MedTrace Logo

Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels

NCT03720704 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2026-04-14

Study results available
· View outcomes & findings →

Summary

The primary objective of the VBX 17-04 registry is to collect post-market safety and performance data of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) in peripheral vessels in patients who require interventional treatment

Conditions

  • Peripheral Vascular Diseases

Interventions

DEVICE

GORE VIABAHN VBX Balloon Expandable Endoprosthesis

GORE VIABAHN VBX Balloon Expandable Endoprosthesis will be implanted in peripheral vessels in patients who require interventional treatment.

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Mauro Gargiulo, MD · Azienda Ospedaliera Policlinico Sant'Orsola Malpighi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-18
Primary Completion
2022-04-13
Completion
2027-07-31
FDA Device
Yes

Countries

  • France
  • Germany
  • Italy
  • Netherlands
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03720704 on ClinicalTrials.gov